Search
for
Sort by
Research 271–300 of 477
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Alopecia areata treated using CO2 fractional laser with different parameters
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Upadacitinib for the treatment of alopecia areata – A case report
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- 1406 Environmental pathobiology of frontal fibrosing alopecia (FFA): A link between linalool sensitization and FFA development
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 382 Environmental pathobiology of frontal fibrosing alopecia (FFA): Does linalool promote FFA development and progression by inducing epithelial hair follicle stem cell damage and MICA expression in the bulge?
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- ESDR382 - Environmental pathobiology of frontal fibrosing alopecia (FFA): Does linalool promote FFA development and progression by inducing epithelial hair follicle stem cell damage and MICA expression in the bulge?
- Effects of biomaterials derived from germinated hemp seeds for stressed hair stem cells and immune cells
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Comprehensive transcriptome and methylome analysis delineates the biological basis of hair follicle development and wool-related traits in Merino sheep